Galantamine API (CAS No. 357-70-0) is a tertiary alkaloid and cholinesterase inhibitor associated with neurological pharmaceutical formulations. Galantamine is pharmacologically classified as a competitive and reversible inhibitor of acetylcholinesterase and is widely associated with pharmaceutical products developed for mild to moderate dementia of the Alzheimer's type.
Galantamine enhances cholinergic activity by inhibiting the hydrolysis of acetylcholine through reversible acetylcholinesterase inhibition. This increases the availability of acetylcholine within cholinergic neuronal pathways and supports its established role in antidementia pharmaceutical products.
Pharmaceutical companies sourcing Galantamine API commonly evaluate assay, HPLC purity, stereochemical identity, specific rotation, related substances, process-related impurities, degradation products, residual solvents, water content, crystalline characteristics, and batch-to-batch consistency.
Because Galantamine contains defined stereocenters, stereochemical control is an important consideration during API qualification. Pharmaceutical buyers may review specific optical rotation, chiral purity, epimer-related impurities, chromatographic purity, and consistency of the API impurity profile.
Galantamine is commonly formulated pharmaceutically as Galantamine Hydrobromide. Therefore, API procurement teams should clearly distinguish between Galantamine free base and Galantamine Hydrobromide when evaluating CAS number, molecular weight, specification, and regulatory documentation.
Swapnroop Drugs and Pharmaceuticals supplies Galantamine API for pharmaceutical research, formulation development, generic drug development, analytical requirements, and regulated manufacturing applications with product-specific quality documentation, pharmaceutical-grade packaging, and reliable supply-chain coordination.
Pharmaceutical companies evaluating Galantamine API commonly focus on:
Stereochemical consistency is particularly important for Galantamine API because the molecule contains defined stereocenters. Chiral purity and optical rotation may therefore form important components of API release and supplier qualification requirements.
Galantamine API is primarily associated with:
Commercially marketed galantamine products commonly use Galantamine Hydrobromide and are associated with treatment of mild to moderate dementia of the Alzheimer's type.
Galantamine is associated with pharmaceutical development focused on cholinergic neurotransmission and acetylcholinesterase inhibition.
Pharmaceutical formulation companies evaluating Galantamine API may review:
Product-specific API specifications should be evaluated according to the intended dosage form, salt form, target regulatory market, and approved pharmaceutical development requirements.
Galantamine free base and Galantamine Hydrobromide should be treated as separate pharmaceutical material identities.
Galantamine free base has CAS No. 357-70-0, molecular formula C17H21NO3, and molecular weight 287.35 g/mol.
Galantamine Hydrobromide is the hydrobromide salt form commonly associated with marketed pharmaceutical dosage forms. Procurement and regulatory teams should confirm the required salt form before placing a commercial enquiry.
Swapnroop Drugs and Pharmaceuticals supports pharmaceutical customers with:
Galantamine API is supplied in secure pharmaceutical-grade packaging selected according to product quantity, stability requirements, moisture protection requirements, and customer specifications.
Product-appropriate inner polyethylene liners and approved pharmaceutical-grade outer containers or HDPE drums may be used according to the supplied material specification.
Available packaging configurations may include:
Packaging configuration, MOQ, commercial quantity, and shipment requirements are confirmed according to the approved product specification and customer enquiry.
Store Galantamine API in tightly closed and appropriately labeled containers under recommended controlled storage conditions.
Protect the material from excessive moisture, heat, direct light, and unsuitable environmental exposure.
Product-specific storage requirements should be followed according to the approved specification, SDS, COA, and stability documentation.
Handling should be performed by trained personnel using approved pharmaceutical raw material handling procedures and applicable safety documentation.
Swapnroop Drugs and Pharmaceuticals provides Galantamine API bulk supply and export support in India for qualified pharmaceutical manufacturers, formulation developers, research organizations, generic drug companies, and pharmaceutical procurement customers.
For Galantamine API price, CAS No. 357-70-0, specification, HPLC purity, chiral purity, COA availability, MOQ, particle size requirements, packaging, and export enquiries, contact our pharmaceutical sales team.
Get Bulk Quote via WhatsApp